Variables | N | NDRG2 expression | Â | |
---|---|---|---|---|
 |  | Low expression, n(%) | High expression, n(%) | P-value |
Age (years) | Â | Â | Â | 0.104b |
  ≤50 | 112 | 72 (64.3) | 40 (35.7) |  |
  >50 | 157 | 85 (54.1) | 72 (45.9) |  |
Tumour size | Â | Â | Â | 0.536b |
  ≤2 cm | 121 | 68 (56.2) | 53 (43.8) |  |
  >2 cm | 148 | 89 (60.1) | 59 (39.9) |  |
TNM stage | Â | Â | Â | <0.0001b |
  I to II | 114 | 48 (42.1) | 66 (57.9) |  |
  III to IV | 155 | 109 (70.3) | 46 (29.7) |  |
Lymph node metastasis | Â | Â | Â | 0.009b |
  Negative | 114 | 56 (49.1) | 58 (50.9) |  |
  Positive | 155 | 101 (65.2) | 54 (34.8) |  |
Histology | Â | Â | Â | <0.0001c |
  Poorly differentiated | 103 | 75 (72.8) | 28 (27.2) |  |
  Moderately differentiated | 83 | 52 (62.7) | 31 (37.3) |  |
  Well differentiated | 83 | 30 (36.1) | 53 (63.9) |  |
Tumour invasion | Â | Â | Â | 0.387b |
  No | 134 | 82 (61.2) | 52 (38.8) |  |
  Yes | 135 | 75 (55.6) | 60 (44.4) |  |
ER status | Â | Â | Â | 0.010b |
  Negative | 79 | 56 (70.9) | 23 (29.1) |  |
  Positive | 190 | 101 (53.2) | 89 (46.8) |  |
Her-2 status | Â | Â | Â | 0.010b |
  Negative | 201 | 108 (53.7) | 93 (46.3) |  |
  Positive | 68 | 49 (72.1) | 19 (27.9) |  |
Ki67 status | Â | Â | Â | 0.006b |
  Negative | 119 | 58 (48.7) | 61 (51.3) |  |
  Positive | 150 | 99 (66.0) | 51 (34.0) |  |